Li Hua Zheng
Fondatore presso AnHeart Therapeutics (Hangzhou) Co., Ltd.
Posizioni attive di Li Hua Zheng
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
AnHeart Therapeutics (Hangzhou) Co., Ltd.
 AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | Direttore/Membro del Consiglio | 27/11/2018 | - |
| Fondatore | 27/11/2018 | - | |
| Corporate Officer/Principal | 27/11/2018 | - | |
| Anbio, Inc. | Direttore/Membro del Consiglio | 01/12/2017 | - |
| Fondatore | 01/12/2017 | - | |
| Zheng & Karg LLP | Corporate Officer/Principal | 01/01/2018 | - |
Storia della carriera di Li Hua Zheng
Precedenti posizioni note di Li Hua Zheng
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Liu, Zheng, Chen & Hoffman LLP | Corporate Officer/Principal | 01/10/2015 | 01/12/2017 |
| UCOMMUNE INTERNATIONAL LTD | Direttore/Membro del Consiglio | 01/12/2018 | - |
| Independent Dir/Board Member | 01/12/2018 | - |
Formazione di Li Hua Zheng
| Fordham University School of Law | Graduate Degree |
| Baylor College of Medicine | Doctorate Degree |
| Fudan University | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| Cina | 3 |
Posizioni
| Corporate Officer/Principal | 3 |
| Director/Board Member | 3 |
| Graduate Degree | 2 |
Settori
| Consumer Services | 4 |
| Finance | 2 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 5 |
|---|---|
Orisun Acquisition Corp.
 Orisun Acquisition Corp. Financial ConglomeratesFinance Orisun Acquisition Corp. is a blank check company, which engages in the provision of merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination, with one or more target businesses. The company was founded on October 22, 2018 and is headquartered in New York, NY. | Finance |
AnHeart Therapeutics (Hangzhou) Co., Ltd.
AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | Commercial Services |
| Anbio, Inc. | |
| Zheng & Karg LLP | |
| Liu, Zheng, Chen & Hoffman LLP |
- Borsa valori
- Insiders
- Li Hua Zheng
- Esperienza
